Short description
AveXis is a Biotech company is focused on developing gene therapy for patients with rare and life-threatening neurological genetic diseases.
Description
AveXis , doing business as Novartis Gene Therapies, Inc., is a biotechnology company that specializes in the development and commercialization of gene therapies for patients and families affected by rare and life-threatening neurological genetic diseases.
AveXis was acquired by Novartis on May 14, 2018. In 2020, the company was renamed Novartis Gene Therapies.
Last funding
No Way
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
Dallas, Texas, United States, North America
Founded on
January 1, 2013
Exited on
February 11, 2016
Went public on
February 11, 2016
Delisted on
May 15, 2018
Stock symbol
AVXS
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$1230 - 4560
Sign in for full access
Investors
Noway Youcantaccess, Uh Ohhhh, Uh Ohhhh, Noaccess, Noaccess, Cannot Access, Absolutely Noaccess, Cannot Access, Uh Ohhhh, Noaccessforu, Noaccessforu, Noway Youcantaccess, Cannot Access
Sign in for full access
Founders
John A. Carbona, Sean P. Nolan